Viewing Study NCT05765604

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:58 PM

Ignite Modification Date: 2025-12-25 @ 5:32 PM

Study NCT ID: NCT05765604

Status: COMPLETED

Last Update Posted: 2025-03-26

First Post: 2023-03-10

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)

Sponsor: WestVac Biopharma Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module